5
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Effect of Indomethacin on Peripheral Tissue Perfusion After Coronary Artery Bypass Surgery

&
Pages 247-251 | Accepted 24 Feb 1989, Published online: 12 Jul 2009
 

Abstract

The effect of indomethacin on peripheral tissue perfusion in the early phase after coronary artery bypass grafting (CABG) was investigated in ten patients randomly allocated to receive indomethacin 25 mg i.v. or placebo ‘double-blind’. The patients were coupled to a respirator with FiO2 30 v/v%. Central haemodynamics, intrapulmonary shunt and blood gases showed no significant change in either group during the 2-hour study period. The thromboxane A2 metabolite P-TXB2 decreased significantly (p<0.05) in the indomethacin group, but the prostacyclin metabolite P-6-K PGF showed no significant change in either group. The PtcO2 index (transcutaneous oxygen tension/arterial PO2), measured in the upper extremity, rose (p<0.05) after indomethacin infusion, but was almost unchanged in the controls. The mean subcutaneous tissue oxygen tension and the laser-Doppler skin red-cell flux underwent no significant change. The data thus suggested that indomethacin administered intravenously post-CABG may exert beneficial effects on peripheral tissue perfusion and oxygenation, possibly mediated by improvements in prostacyclin-thromboxane balance and microcirculation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.